Name
PUBLIC HEALTH PARALLEL 3 - Interventions to enhance testing, treatment, and viral elimination
Date & Time
Wednesday, March 19, 2025, 3:30 PM - 5:00 PM
Speakers
Oluwaseun (Seun) Falade-Nwulia, Johns Hopkins University
Maka Gogia, Georgian Harm Reduction Network
Alethea Raelyn Yi Tan, Clinton Health Access Initiative
Alexander Stockdale, University of Liverpool
Peter Vickermn, University of Bristol
Su Wang, Cooperman Barnabas Medical Center, RWJBH| Hepatitis B Foundation
Maka Gogia, Georgian Harm Reduction Network
Alethea Raelyn Yi Tan, Clinton Health Access Initiative
Alexander Stockdale, University of Liverpool
Peter Vickermn, University of Bristol
Su Wang, Cooperman Barnabas Medical Center, RWJBH| Hepatitis B Foundation
Description
- Interventions to enhance linkage to hepatitis C care and treatment (not diagnostic strategies - e.g. electronic medical record audit, financial incentives, peer support, pharmacy starter packs) Seun Falade-Nwulia
- Interventions to enhance linkage to hepatitis B & D care and treatment (not diagnostic strategies) Alexander Stockdale
- Oral Presentation: LINKAGE TO CARE OF PEOPLE WHO INJECT DRUGS WITHIN NATIONAL HEPATITIS C ELIMINATION PROGRAM IN GEORGIA Maka Gogia
- Oral Presentation: EVALUATING THE IMPACT OF INCREASED PROVISION OF LOW DEAD SPACE SYRINGES ON HIV AND HCV TRANSMISSION AMONG PEOPLE WHO INJECT DRUGS: A MODELLING ANALYSIS FOR 19 COUNTRIES Peter Vickerman
- Oral Presentation: OPTIMIZING HEALTHCARE SYSTEMS FOR VIRAL HEPATITIS ELIMINATION: AUTOMATING EMR-BASED HEPATITIS B AND C SCREENING Su Wang
- Oral Presentation: ACHIEVEMENTS AND CHALLENGES IN SCALING HCV SERVICES TO PRIMARY HEALTHCARE (PHC) FACILITIES IN CAMBODIA Alethea Tan
- Q&A